fda warning letters glp-1 compounders september 2025 news 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA Issues Warnings Against Illegal
Description
People sometimes stack peptides or use additional medications to optimize results
[DOI] [PubMed] [Google Scholar] 86.Alferink L.J.M., Erler N.S., de Knegt R.J., et al
The day of weekly administration can be changed if needed as long as the time between 2 doses is at least 2 days (greater than 48 hours)
Research published in a 2025 narrative review found that GLP-1 medications can lead to muscle loss, micronutrient deficiencies, and digestive disruptions if nutritional needs aren't actively managed
Rev Endocr Metab Disorders
Strengthen existing hair to reduce breakage
